ERIN STUCKWISH: Open Payments
NPI 1447865498 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 103 payments from 21 companies in 2025. Trend: 2023 $1,482 · 2024 $1,921 · 2025 $1,831
Food & beverage: $1,831
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $307 |
| AstraZeneca Pharmaceuticals LP | 9 | $201 |
| ABBVIE INC. | 13 | $162 |
| Lilly USA, LLC | 11 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $143 |
| Merck Sharp & Dohme LLC | 8 | $136 |
| PFIZER INC. | 6 | $123 |
| Novartis Pharmaceuticals Corporation | 6 | $120 |
| Amgen Inc. | 5 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
Products named: Ozempic, Kerendia, MOUNJARO, JARDIANCE, PIFELTRO, VRAYLAR, Rybelsus, LEQVIO.
Industry payments across IN — which companies pay providers there.
